TY - JOUR T1 - Magnetization Transfer Imaging in Premanifest and Manifest Huntington Disease JF - American Journal of Neuroradiology JO - Am. J. Neuroradiol. DO - 10.3174/ajnr.A2868 AU - S.J.A. van den Bogaard AU - E.M. Dumas AU - J. Milles AU - R. Reilmann AU - J.C. Stout AU - D. Craufurd AU - M.A. van Buchem AU - J. van der Grond AU - R.A.C. Roos Y1 - 2012/01/12 UR - http://www.ajnr.org/content/early/2012/01/12/ajnr.A2868.abstract N2 - BACKGROUND AND PURPOSE: MTI has the potential to detect abnormalities in normal-appearing white and gray matter on conventional MR imaging. Early detection methods and disease progression markers are needed in HD research. Therefore, we investigated MTI parameters and their clinical correlates in premanifest and manifest HD. MATERIALS AND METHODS: From the Leiden TRACK-HD study, 78 participants (28 controls, 25 PMGC, 25 MHD) were included. Brain segmentation of cortical gray matter, white matter, caudate nucleus, putamen, pallidum, thalamus, amygdala, and hippocampus was performed using FSL's automated tools FAST and FIRST. Individual MTR values were calculated from these regions and MTR histograms constructed. Regression analysis of MTR measures from all gene carriers with clinical measures was performed. RESULTS: MTR peak height was reduced in both cortical gray (P = .01) and white matter (P = .006) in manifest HD compared with controls. Mean MTR was also reduced in cortical gray matter (P = .01) and showed a trend in white matter (P = .052). Deep gray matter structures showed a uniform pattern of reduced MTR values (P < .05). No differences between premanifest gene carriers and controls were found. MTR values correlated with disease burden and motor and cognitive impairment. CONCLUSIONS: Throughout the brain, disturbances in MTI parameters are apparent in early HD and are homogeneous across white and gray matter. The correlation of MTI with clinical measures indicates the potential to act as a disease monitor in clinical trials. However, our study does not provide evidence for MTI as a marker in premanifest HD. Abbreviations CAGcytosine-adenosine-guanineHDHuntington diseaseMHDearly manifest HD patientsMMSEMini-Mental State ExaminationMTImagnetization transfer imagingMTRmagnetization transfer ratioPMGCpremanifest HD gene carriersUHDRSUnited Huntington's Disease Rating Scale ER -